Have a personal or library account? Click to login
Ultrasound methods of imaging atherosclerotic plaque in carotid arteries: examinations using contrast agents Cover

Ultrasound methods of imaging atherosclerotic plaque in carotid arteries: examinations using contrast agents

Open Access
|Sep 2020

References

  1. Grabowska-Fudala B, Jaracz K, Górna K: Zapadalność, śmiertelność i umieralność z powodu udarów mózgu – aktualne tendencje i prognozy na przyszłość. Przegl Epidemiol 2010; 64: 439–442.
  2. Blaser T, Hofmann K, Buerger T, Effenberger O, Wallesch CW, Goertler M: Risk of stroke, transient ischemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. Stroke 2002; 33: 1057–1062.
  3. De Blois J, Stranden E, Jogestrand T, Henareh L, Agewall S: Echogenicity of the carotid intima-media complex and cardiovascular risk factors. Clin Physiol Funct Imaging 2012; 32: 400–403.
  4. Degnan AJ, Young VE, Gillard JH: Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis. Expert Rev Cardiovasc Ther 2012; 10: 37–53.
  5. Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ: Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg (Torino) 1988; 29: 676–681.
  6. Kawasaki M: An integrated backscatter ultrasound technique for the detection of coronary and carotid atherosclerotic lesions. Sensors (Basel) 2015; 15: 979–994.
  7. Casscells W, Naghavi M, Willerson JT: Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003; 107: 2072–2075.
  8. den Hartog AG, Achterberg S, Moll FL, Kappelle LJ, Visseren FL, van der Graaf Y et al.: Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with clinical manifest arterial disease. Stroke 2013; 44: 1002–1007.
  9. Dweck MR, Fayad ZA: Multitarget Vulnerable Plaque Imaging. Circ Cardiovasc Imaging 2017; 10.
  10. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R: Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30: 1282–1292.
  11. Fleg JL, Stone GW, Fayad ZA, Granada JF, Hatsukami TS, Kolodgie FD et al.: Detection of high-risk atherosclerotic plaque: report of the NHL-BI Working Group on current status and future directions. JACC Cardiovasc Imaging, 2012; 5: 941–955.
  12. Virmani R, 2006.
  13. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the unstable plaque. Prog Cardiovasc Dis 2002; 44: 349–356.
  14. Virmani R, Burke AP, Kolodgie FD, Farb A: Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 2003; 16: 267–272.
  15. Calcagno C, Robson PM, Ramachandran S, Mani V, Kotys-Traughber M, Cham M et al.: SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries. J Cardiovasc Magn Reson 2013; 15: 42.
  16. Carra G, Visonà A, Bonanome A, Lusiani L, Pesavento R, Bortolon M et al.: Carotid plaque morphology and cerebrovascular events. Int Angiol, 2003; 22: 284–284.
  17. Constantinides P: Overview of studies on regression of atherosclerosis. Artery 1981; 9: 30–43.
  18. Constantinides P: Cause of thrombosis in human atherosclerotic arteries. Am J Cardiol 1990; 66: 37G–40G.
  19. Di Stefano R, Felice F, Balbarini A: Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 2009; 15: 1095–1106.
  20. Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R et al.: Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 2004; 110: 2843–2850.
  21. Marques JS, Pinto FJ: The vulnerable plaque: current concepts and future perspectives on coronary morphology, composition and wall stress imaging. Rev Port Cardiol 2014; 33: 101–110.
  22. Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, Virmani R: Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol 2007; 49: 2093–2101.
  23. Kashiwazaki D, Yoshimoto T, Mikami T, Muraki M, Fujimoto S, Abiko K et al.: Identification of high-risk carotid artery stenosis: motion of intraplaque contents detected using B-mode ultrasonography. J Neurosurg 2012; 117: 574–578.
  24. Lechareas S, Yanni AE, Golemati S, Chatziioannou A, Perrea D: Ultrasound and biochemical diagnostic tools for the characterization of vulnerable carotid atherosclerotic plaque. Ultrasound Med Biol, 2016; 42: 31–43.
  25. Clevert DA, Paprottka P, Sommer WH, Helck A, Reiser MF, Zengel P: The role of contrast-enhanced ultrasound in imaging carotid arterial diseases. Semin Ultrasound CT MR, 2013; 34: 204–212.
  26. Feinstein SB: Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 2006; 48: 236–243.
  27. Iezzi R, Petrone G, Ferrante A, Lauriola L, Vincenzoni C, la Torre MF et al.: The role of contrast-enhanced ultrasound (CEUS) in visualizing atherosclerotic carotid plaque vulnerability: which injection protocol? Which scanning technique? Eur J Radiol 2015; 84: 865–871.
  28. Salem MK, Bown MJ, Sayers RD, West K, Moore D, Nicolaides A et al.: Identification of patients with a histologically unstable carotid plaque using ultrasonic plaque image analysis. Eur J Vasc Endovasc Surg 2014; 48: 118–125.
  29. Bokor D: Diagnostic efficacy of SonoVue. Am J Cardiol 2000; 86: 19G–24G.
  30. Coli S, Magnoni M, Sangiorgi G, Marrocco-Trischitta, Melisurgo G, Mauriello A et al.: Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008; 52: 223–230.
  31. Droste DW: Clinical utility of contrast-enhanced ultrasound in neurosonology. Eur Neurol 2008; 59 Suppl 1: 2–8.
  32. Fürst G, Sitzer M, Hofer M, Steinmetz H, Hackländer T, Mödder U: [Contrast-enhanced color-coded duplex ultrasound of high grade carotid stenoses]. Ultraschall Med 1995; 16: 140–144.
  33. Shah F, Balan P, Weinberg M, Reddy V, Neems R, Feinstein M et al.: Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med 2007; 12: 291–297.
  34. Tremblay-Darveau C, Sheeran PS, Vu CK, Williams R, Zhang Z, Bruce M et al.: The role of microbubble echo phase lag in multipulse contrast-enhanced ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2018; 65: 1389–1401.
  35. van Gils MJ, Vukadinovic D, van Dijk AC, Dippel DW, Niessen WJ, van der Lugt: Carotid atherosclerotic plaque progression and change in plaque composition over time: a 5-year follow-up study using serial CT angiography. AJNR Am J Neuroradiol 2012; 33: 1267–1273.
  36. Varetto G, Gibello L, Castagno C, Quaglino S, Ripepi M, Benintende E et al.: Use of contrast-enhanced ultrasound in carotid atherosclerotic disease: limits and perspectives. Biomed Res Int 2015; 2015: 293163.
  37. Averkiou MA Bruce MF, Powers JE, Sheeran PS, Burns PN: Imaging methods for ultrasound contrast agents. Ultrasound Med Biol 2020; 46: 498–517.
  38. Rafailidis V, Chryssogonidis I, Xerras C, Nicolau I, Tegos T, Kouskouras K et al.: A comparative study of color Doppler imaging and contrast-enhanced ultrasound for the detection of ulceration in patients with carotid atherosclerotic disease. Eur Radiol 2019; 29: 2137–2145.
  39. Rafailidis V, Huang DY, Yusuf GT, Sidhu PS: General principles and overview of vascular contrast-enhanced ultrasonography. Ultrasonography 2020; 39: 22–42.
  40. Artas H, Okcesiz I: Three-dimensional ultrasonographic evaluation of carotid artery plaque surface irregularity. Arch Med Sci 2020; 16: 58–65.
  41. Calogero E, Fabiani I, Pugliese NR, Santini V, Ghiadoni L, Di Stefano R et al.: Three-dimensional echographic evaluation of carotid artery disease. J Cardiovasc Echogr 2018; 28: 218–227.
  42. Rafailidis V, Chryssogonidis I, Tegos T, Kouskouras K, Charitanti-Kouridou A: Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature. Insights Imaging 2017; 8: 213–213.
  43. Muraki M, Mikami T, Yoshimoto T, Fujimoto S, Kitaguchi M, Kaga S et al.: Sonographic detection of abnormal plaque motion of the carotid artery: its usefulness in diagnosing high-risk lesions ranging from plaque rupture to ulcer formation. Ultrasound Med Biol 2016; 42: 358–364.
  44. Ohyama H, Mizushige K, Takahashi T, Hosomi N, Kohno M: Plaque rupture on the carotid artery observed by Doppler ultrasonography – a case report. Angiology 2001; 52: 867–869.
  45. Rübenthaler J, Reiser M, Clevert DA: Diagnostic vascular ultrasonography with the help of color Doppler and contrast-enhanced ultrasonography. Ultrasonography 2016; 35: 289–301.
  46. Jashari F, Ibrahim P, Johansson E, Grönlund C, Wester P, Henein MY: Carotid IM-GSM is better than IMT for identifying patients with multiple arterial disease. Scand Cardiovasc J 2018; 52: 93–99.
  47. Sztajzel R, Momjian S, Momjian-Mayor I, Murith N, Djebaili K, Boissard G et al.: Stratified gray-scale median analysis and color mapping of the carotid plaque: correlation with endarterectomy specimen histology of 28 patients. Stroke 2005; 36: 741–745.
  48. Hoogi A, Adam D, Hoffman A, Kerner H, Reisner S, Gaitini D: Carotid plaque vulnerability: quantification of neovascularization on contrast-enhanced ultrasound with histopathologic correlation. AJR Am J Roentgenol 2011; 196: 431–436.
  49. Akkus Z, Hoogi A, Renaud G, van den Oord AC, Ten Kate GL, Schinkel AF et al.: New quantification methods for carotid intra-plaque neovascularization using contrast-enhanced ultrasound. Ultrasound Med Biol 2014; 40: 25–36.
  50. Akkus Z, van Burken G, van den Oord, Schinkel AF, de Jong N, van der Steen AF et al.: Carotid intraplaque neovascularization quantification software (CINQS). IEEE J Biomed Health Inform 2015; 19: 332–338.
DOI: https://doi.org/10.15557/jou.2020.0032 | Journal eISSN: 2451-070X | Journal ISSN: 2084-8404
Language: English
Page range: 191 - 200
Submitted on: Mar 23, 2020
Accepted on: Jul 11, 2020
Published on: Sep 28, 2020
Published by: MEDICAL COMMUNICATIONS Sp. z o.o.
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Andrzej Fedak, Robert Chrzan, Ositadima Chukwu, Andrzej Urbanik, published by MEDICAL COMMUNICATIONS Sp. z o.o.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.